» Articles » PMID: 31792377

STRIPAK Integrates Upstream Signals to Initiate the Hippo Kinase Cascade

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2019 Dec 4
PMID 31792377
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

The Hippo pathway plays a critical role in development, tissue homeostasis and organ size; its dysregulation contributes to human diseases. Although MST1/2 and the MAP4Ks are well known as the Hippo kinases, a major open question is how these kinases are regulated by upstream signals. Here we report that STRIPAK integrates upstream signals to control the activities of MST1/2 and the MAP4Ks, thus initiating Hippo signalling. STRIPAK also serves as a master regulator for the STE20 family kinases. Following serum or lysophosphatidic acid stimulation, active RhoA binds and dissociates rhophilin and NF2/Kibra from STRIPAK, thereby inducing the association and dephosphorylation of MST1/2 and MAP4Ks by the STRIPAK phosphatase catalytic subunit PP2AC. Rhophilin suppresses cancer cell growth by activating the Hippo pathway. Our study reveals a RhoA-rhophilin-NF2/Kibra-STRIPAK signalling axis in Hippo regulation, thus addressing the key question of how Hippo signalling is initiated and suggesting a broad and active role for STRIPAK in cellular signalling.

Citing Articles

Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.

Ma X, Huang T, Chen X, Li Q, Liao M, Fu L Signal Transduct Target Ther. 2025; 10(1):63.

PMID: 39920130 PMC: 11806117. DOI: 10.1038/s41392-024-02104-8.


Regulation of trophectoderm morphogenesis by small GTPase RHOA through HIPPO signaling-dependent and -independent mechanisms in mouse preimplantation development.

Marikawa Y, Alarcon V Differentiation. 2025; 141:100835.

PMID: 39874642 PMC: 11790356. DOI: 10.1016/j.diff.2025.100835.


PCYT2 inhibits epithelial-mesenchymal transition in colorectal cancer by elevating YAP1 phosphorylation.

Zhou L, Zhang S, Wang L, Liu X, Yang X, Qiu L JCI Insight. 2024; 9(24).

PMID: 39531326 PMC: 11665560. DOI: 10.1172/jci.insight.178823.


STRIPAK, a fundamental signaling hub of eukaryotic development.

Kuck U, Poggeler S Microbiol Mol Biol Rev. 2024; 88(4):e0020523.

PMID: 39526753 PMC: 11653735. DOI: 10.1128/mmbr.00205-23.


Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application.

Su L, Bu J, Yu J, Jin M, Meng G, Zhu X Clin Transl Med. 2024; 14(11):e70066.

PMID: 39462685 PMC: 11513202. DOI: 10.1002/ctm2.70066.


References
1.
Pan D . The hippo signaling pathway in development and cancer. Dev Cell. 2010; 19(4):491-505. PMC: 3124840. DOI: 10.1016/j.devcel.2010.09.011. View

2.
Halder G, Camargo F . The hippo tumor suppressor network: from organ size control to stem cells and cancer. Cancer Res. 2013; 73(21):6389-92. PMC: 4030874. DOI: 10.1158/0008-5472.CAN-13-2392. View

3.
Harvey K, Zhang X, Thomas D . The Hippo pathway and human cancer. Nat Rev Cancer. 2013; 13(4):246-57. DOI: 10.1038/nrc3458. View

4.
Johnson R, Halder G . The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2013; 13(1):63-79. PMC: 4167640. DOI: 10.1038/nrd4161. View

5.
Yu F, Zhao B, Guan K . Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell. 2015; 163(4):811-28. PMC: 4638384. DOI: 10.1016/j.cell.2015.10.044. View